NICE backs Astra, Bristol diabetes drug in some cases

[riky]

NICE backs Astra, Bristol diabetes drug in some cases

LONDON (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new diabetes drug from Bristol-Myers Squibb and AstraZeneca in some circumstances, marking a change of tack following an earlier blanket rejection. The National Institute for Health and Clinical Excellence (NICE) said on Thursday that Forxiga, or dapagliflozin, was a cost-effective option for type 2 diabetes when used in combination with the older medicine metformin. ...

Source: You are not allowed to view links. Register or Login